WeightWatchers: As Australian members mourn meetings, could off-brand Ozempic be program’s saviour?
Will the brand really follow through on their cancellations? And could compounded semaglutide be the once-housewife-favourite ...
NBC220h
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...
France won’t pay for weight loss drug Wegovy. What about other European countries?
France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...
WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model'
WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say that's only a short-term solution to its ailing business.
Weight Watchers Stock Rises 38% On Plan To Sell Obesity Drugs
Shares of Weight Watchers parent company WW International (WW) rose nearly 40% after the company announced plans to begin ...
clickondetroit.com2d
Low insurance coverage hampers access to weight-loss medications
In addition to availability, the cost of weight loss drugs like Wegovy and Zepbound is a major barrier preventing many ...
Hosted on MSN2d
WeightWatchers (NASDAQ:WW) Stock Jumps 40% on Plan to Sell Obesity Medications
Shares of WeightWatchers parent company WW International ($WW) have rocketed 40% higher on news that the company plans to ...
What's Going With WeightWatchers Stock On Wednesday?
WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while ...
WeightWatchers offering compounded version of Ozempic, despite concerns expressed by FDA
High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...
bovnews3d
WeightWatchers (WW) Surges in Premarket Trading: A Closer Look at Recent Developments
WeightWatchers recently announced the inclusion of compounded semaglutide into its suite of offerings. This new clinical weight management intervention aims to broaden access for eligible members who ...
WAOW3d
Your employer may start covering weight-loss drugs soon
Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, ...
WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications
WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight ...